Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Methotrexate Market

Methotrexate Market Share

Report ID: GMI6835
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Methotrexate Market Share

Some of the eminent market participants operating in the methotrexate market include:

Novartis AG (Sandoz)
Merck & Co., Inc
Lonza
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma Ltd
Fermion (Orion Corporation)
Avra Laboratories Pvt Ltd
LGM Pharma
Rochem International Inc

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global methotrexate industry was valued at USD 553 million in 2022 and is estimated to account for USD 921 million by 2032 as methotrexate is a versatile medication that is used to treat a variety of medical conditions, including cancer, autoimmune diseases, and severe skin disorders.

Rheumatoid arthritis (RA) segment accounted for over USD 250 million in the year 2022, supported by the growing prevalence of people suffering from the disease in developed as well as developing economies.

U.S. methotrexate market accounted for USD 165.3 million in 2022 and is predicted to witness substantial growth through 2032, attributed to the significant healthcare expenditure, supportive government initiatives, high number of pharmaceutical companies, and rising disease awareness.

Novartis AG (Sandoz), Merck & Co., Inc, Lonza, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd, Fermion (Orion Corporation), Avra Laboratories Pvt Ltd, LGM Pharma, and Rochem International Inc among others.